| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.17 | 0.005 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.17 | 0.005 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.005 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.005 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.005 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.091 | 0.005 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.082 | 0.006 |